ES2085035T3 - Soporte de particulas solidas de lipidos para medicamentos (nanoesferas solidas de lipidos (sln)). - Google Patents
Soporte de particulas solidas de lipidos para medicamentos (nanoesferas solidas de lipidos (sln)).Info
- Publication number
- ES2085035T3 ES2085035T3 ES92919477T ES92919477T ES2085035T3 ES 2085035 T3 ES2085035 T3 ES 2085035T3 ES 92919477 T ES92919477 T ES 92919477T ES 92919477 T ES92919477 T ES 92919477T ES 2085035 T3 ES2085035 T3 ES 2085035T3
- Authority
- ES
- Spain
- Prior art keywords
- solid lipid
- sln
- spheres
- medicines
- support
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5123—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
Abstract
LOS SOPORTES DE MEDICACION DISPONEN DE PARTICULAS OBTENIDAS A PARTIR DE MATERIALES LIPIDOS, SIMILARES A LIPIDOS (LIPOIDES) O MEZCLA DE ELLOS, CON UN DIAMETRO DESDE 10 NM HASTA 10 MICRAS, QUE SON SOLIDOS A TEMPERATURA AMBIENTE. DEBIDO A SU NUCLEO SOLIDO, ESTOS SOPORTES DE MEDICACION PERMITEN SUSTANCIAS ACTIVAS QUE SON CONTROLADAS UNA VEZ LIBERADAS DURANTE UN LARGO PERIODO, PERMITIENDO A LOS MEDICAMENTOS HIDROFILICOS QUE SEAN INCORPORADOS EN EL NUCLEO SOLIDO Y SEAN DE DESCOMPOSICION RELATIVAMENTE RAPIDA, NO PRODUCIENDO PRODUCTOS TOXICOS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4131562A DE4131562A1 (de) | 1991-09-18 | 1991-09-18 | Arzneistofftraeger aus festen lipidteilchen-feste lipidnanosphaeren (sln) |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2085035T3 true ES2085035T3 (es) | 1996-05-16 |
ES2085035T5 ES2085035T5 (es) | 1999-06-16 |
Family
ID=6441225
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES92919477T Expired - Lifetime ES2085035T5 (es) | 1991-09-18 | 1992-09-16 | Soporte de particulas solidas de lipidos para medicamentos (nanoesferas solidas de lipidos (sln)). |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0605497B2 (es) |
JP (1) | JP2683575B2 (es) |
KR (1) | KR0141504B1 (es) |
AT (1) | ATE135567T1 (es) |
AU (1) | AU672177B2 (es) |
CA (1) | CA2119253C (es) |
CZ (1) | CZ289253B6 (es) |
DE (2) | DE4131562A1 (es) |
DK (1) | DK0605497T4 (es) |
ES (1) | ES2085035T5 (es) |
GR (2) | GR3019750T3 (es) |
HU (1) | HU227680B1 (es) |
WO (1) | WO1993005768A1 (es) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4308282C2 (de) * | 1993-03-16 | 1994-12-22 | Beiersdorf Ag | Vorzugsweise in Form von Mikrosphärulen vorliegende galenische Matrices |
US5576016A (en) * | 1993-05-18 | 1996-11-19 | Pharmos Corporation | Solid fat nanoemulsions as drug delivery vehicles |
DE4336407A1 (de) * | 1993-10-21 | 1995-04-27 | Rotring Int Gmbh | Wasserfeste Kosmetik |
CA2214029A1 (en) * | 1995-04-25 | 1996-10-31 | Magda Marquet | Single-vial formulations of dna/lipid complexes |
US6465016B2 (en) | 1996-08-22 | 2002-10-15 | Research Triangle Pharmaceuticals | Cyclosporiine particles |
EP1010435B1 (en) * | 1997-09-05 | 2010-11-03 | Maruho K.K. | Nanocapsule preparations for treating intraarticular diseases |
IT1296914B1 (it) | 1997-12-01 | 1999-08-03 | Maria Rosa Gasco | Composizione farmaceutica comprendente microparticelle atte al passaggio transmucosale ed al superamento della barriera |
US8415329B1 (en) | 1998-05-29 | 2013-04-09 | Jagotec Ag | Thermoprotected compositions and process for terminal steam sterilization of microparticle preparations |
BR9915738A (pt) | 1998-11-20 | 2001-10-02 | Rtp Pharma Inc | Micropartìculas estabilizadas em fosfolipìdeos dispersìveis |
DE19856432A1 (de) | 1998-12-08 | 2000-06-15 | Basf Ag | Nanopartikuläre Kern-Schale Systeme sowie deren Verwendung in pharmazeutischen und kosmetischen Zubereitungen |
KR20020011985A (ko) | 1999-05-07 | 2002-02-09 | 파르마솔 게엠베하 | 액상 및 고체상 지질 혼합물에 기초한 지질입자들 및 그의제조방법 |
US7431943B1 (en) * | 1999-06-14 | 2008-10-07 | Cosmo Technologies Limited | Controlled release and taste masking oral pharmaceutical compositions |
US8895064B2 (en) | 1999-06-14 | 2014-11-25 | Cosmo Technologies Limited | Controlled release and taste masking oral pharmaceutical composition |
BR0012445A (pt) * | 1999-07-13 | 2002-04-02 | Pharmasol Gmbh | Agentes com ação absorvente e/ou refletora de radiação uv para proteção contra radiação uv nociva à saúde e para reforçar a barreira natural da pele |
WO2002026272A1 (en) * | 2000-09-29 | 2002-04-04 | Salvona L.L.C. | Multi component controlled release system for sanitary paper products |
EP1269994A3 (en) | 2001-06-22 | 2003-02-12 | Pfizer Products Inc. | Pharmaceutical compositions comprising drug and concentration-enhancing polymers |
KR20010090030A (ko) * | 2001-08-09 | 2001-10-18 | 임정옥 | 경피마취효과가 월등한 혼합형 마취제의 제형방법 |
KR100452165B1 (ko) * | 2002-01-29 | 2004-10-08 | 주식회사 태평양 | 리포펩티드계 보조 계면활성제를 이용한 나노에멀젼 및이를 함유하는 화장료 조성물 |
DE10312763A1 (de) | 2003-03-21 | 2004-09-30 | IFAC Institut für angewandte Colloidtechnologie GmbH & Co. KG | Verfahren zur Herstellung einer SLN-Dispersion |
FR2852843B1 (fr) | 2003-03-24 | 2008-05-23 | Karim Ioualalen | Systeme galenique permettant le masquage du gout |
US8716214B2 (en) | 2003-05-07 | 2014-05-06 | Otc Gmbh | Compositions for the targetted release of fragrances and aromas |
FR2864900B1 (fr) * | 2004-01-09 | 2007-10-12 | Oreal | Dispersion aqueuse de nanocapsules a coeur huileux |
MXPA06010950A (es) * | 2004-03-26 | 2007-04-16 | Cell Therapeutics Europe Srl | Formulaciones en nano-particulas de compuestos de platino. |
EP1674081A1 (de) | 2004-12-23 | 2006-06-28 | KTB Tumorforschungsgesellschaft mbH | Herstellung von lipidbasierten Nanopartikeln unter Einsatz einer dualen asymmetrischen Zentrifuge |
JP4533185B2 (ja) * | 2005-02-24 | 2010-09-01 | 花王株式会社 | 固体脂質粒子製剤 |
BRPI0611433A2 (pt) * | 2005-05-05 | 2010-09-08 | Sanofi Aventis Us Llc | formulações estáveis de nanopartìcula |
CA2627459C (en) | 2005-10-25 | 2011-08-09 | Evonik Degussa Gmbh | Preparations containing hyperbranched polymers |
ITMI20061274A1 (it) * | 2006-06-30 | 2008-01-01 | Consiglio Nazionale Ricerche | Vettori nanoparticellari lipidici contenenti riluzolo e composizioni farmaceutiche che li contengono |
US9114077B2 (en) | 2006-11-17 | 2015-08-25 | Abbvie Deutschland Gmbh & Co Kg | Nanocrystals for use in topical cosmetic formulations and method of production thereof |
EP1982698A1 (de) * | 2007-04-18 | 2008-10-22 | Evonik Degussa GmbH | Präparate zur gesteuerten Freisetzung von bioaktiven Naturstoffen |
EP2108361A1 (de) * | 2008-04-09 | 2009-10-14 | ROVI Cosmetics International GmbH | Emulgierende Mikropartikel aus Lipiden zur Stabilisierung lipophiler Wirkstoffe für die kosmetische Anwendung |
EP2218447B1 (en) | 2008-11-04 | 2017-04-19 | PharmaSol GmbH | Compositions containing lipid micro- or nanoparticles for the enhancement of the dermal action of solid particles |
FR2950253B1 (fr) | 2009-09-24 | 2011-09-23 | Ethypharm Sa | Nanocapsules lipidiques, procede de preparation et utilisation comme medicament |
ES2384060B1 (es) | 2010-03-24 | 2013-09-23 | Lipotec S.A. | Cápsulas de nanopartículas lipídicas. |
GB201021937D0 (en) * | 2010-12-24 | 2011-02-02 | Reckitt & Colman Overseas | Skin sanitizer compositions comprising alcohol based emulsion |
CA2821061A1 (en) | 2010-12-28 | 2012-07-05 | Unilever Plc | Method for production of an emulsion |
US20140079785A1 (en) * | 2011-03-24 | 2014-03-20 | Leo Pharma A/S | Composition comprising lipid nanoparticles and a corticosteroid or vitamin d derivative |
DE102011018499A1 (de) | 2011-04-23 | 2012-10-25 | Emc Microcollections Gmbh | Topische Nanopartikel-Vakzine zur Immunstimulation der dendritischen Zellen in der Haut |
US10154964B2 (en) | 2011-09-07 | 2018-12-18 | Cosmo Technologies Limited | Controlled release and taste masking oral pharmaceutical composition |
DE102011116069A1 (de) | 2011-10-18 | 2013-04-18 | Dr. Rimpler Gmbh | Lipidnanopartikeldispersion, Verfahren zu deren Herstellung sowie ihre Verwendung |
ITBO20130376A1 (it) | 2013-07-18 | 2015-01-19 | Ferbi Srl | Metodo per la preparazione di nanoparticelle lipidiche solide contenenti anticorpi in forma di coppia ionica, mediante la tecnica della coacervazione degli acidi grassi |
WO2016100228A2 (en) * | 2014-12-15 | 2016-06-23 | Nanosphere Health Sciences, Llc | Methods of treating inflammatory disorders and global inflammation with compositions comprising phospholipid nanoparticle encapsulations of nsaids |
CA3089686A1 (en) | 2015-03-10 | 2016-09-15 | Nanosphere Health Sciences, Llc | A nanoparticle drug delivery comprising liquid lipids and cannabinoids encapsulated in a single layer of essential phospholipids |
CZ307681B6 (cs) | 2016-02-29 | 2019-02-13 | Ústav makromolekulární chemie AV ČR, v. v. i. | Fotoaktivovatelná nanočástice pro fotodynamické aplikace, způsob její přípravy, farmaceutická kompozice ji obsahující a jejich použití |
WO2019116062A1 (en) | 2017-12-12 | 2019-06-20 | Lead Biotherapeutics Ltd. | Solid lipid nanoparticle for intracellular release of active substances and method for production the same |
US11504327B1 (en) | 2019-01-21 | 2022-11-22 | Eric Morrison | Method of preparing nanoparticles by hot-melt extrusion |
IT201900009258A1 (it) | 2019-06-17 | 2020-12-17 | R Bio Transfer S R L | Metodo per la preparazione di nanoparticelle lipidiche |
IT201900013353A1 (it) | 2019-07-30 | 2021-01-30 | Univ Della Calabria | Sistema di veicolazione di olio essenziale di bergamotto basato su nanotecnologie, metodo di preparazione del sistema e suoi usi. |
US20230000980A1 (en) | 2021-06-30 | 2023-01-05 | Novocure Gmbh | Compositions and methods for using alternating electric fields to disrupt lipid capsules |
IT202100023570A1 (it) | 2021-09-13 | 2023-03-13 | Bioema S R L S Biotecnologia Energia Mat Ambiente | Metodo per la preparazione di nanoparticelle lipidiche |
DE202023100649U1 (de) | 2023-02-10 | 2023-03-22 | Cineolux Gmbh | Dispersion und Zubereitung zur topischen Anwendung |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3421468A1 (de) * | 1984-06-08 | 1985-12-19 | Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim | Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung |
AU645003B2 (en) * | 1988-11-08 | 1994-01-06 | Takeda Chemical Industries Ltd. | Sustained release preparations |
LU87410A1 (fr) * | 1988-12-20 | 1990-07-10 | Cird | Composition cosmetique ou pharmaceutique contenant des microspheres de polymeres ou de corps gras chargees d'au moins un produit actif |
FR2651680B1 (fr) * | 1989-09-14 | 1991-12-27 | Medgenix Group Sa | Nouveau procede de preparation de microparticules lipidiques. |
FR2657257B1 (fr) * | 1990-01-19 | 1994-09-02 | Rhone Poulenc Sante | Procede de preparation de medicaments sous forme de perles. |
-
1991
- 1991-09-18 DE DE4131562A patent/DE4131562A1/de not_active Withdrawn
-
1992
- 1992-09-16 DK DK92919477T patent/DK0605497T4/da active
- 1992-09-16 WO PCT/EP1992/002132 patent/WO1993005768A1/de active IP Right Grant
- 1992-09-16 AT AT92919477T patent/ATE135567T1/de active
- 1992-09-16 AU AU25615/92A patent/AU672177B2/en not_active Expired
- 1992-09-16 ES ES92919477T patent/ES2085035T5/es not_active Expired - Lifetime
- 1992-09-16 CA CA002119253A patent/CA2119253C/en not_active Expired - Lifetime
- 1992-09-16 CZ CZ1994596A patent/CZ289253B6/cs not_active IP Right Cessation
- 1992-09-16 DE DE59205783T patent/DE59205783D1/de not_active Expired - Lifetime
- 1992-09-16 JP JP5505769A patent/JP2683575B2/ja not_active Expired - Lifetime
- 1992-09-16 HU HU9400779A patent/HU227680B1/hu unknown
- 1992-09-16 EP EP92919477A patent/EP0605497B2/de not_active Expired - Lifetime
- 1992-09-16 KR KR1019940700886A patent/KR0141504B1/ko not_active IP Right Cessation
-
1996
- 1996-04-24 GR GR960401147T patent/GR3019750T3/el unknown
-
1999
- 1999-05-20 GR GR990401377T patent/GR3030291T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
ES2085035T5 (es) | 1999-06-16 |
JPH06510772A (ja) | 1994-12-01 |
AU2561592A (en) | 1993-04-27 |
ATE135567T1 (de) | 1996-04-15 |
CA2119253A1 (en) | 1993-04-01 |
EP0605497A1 (de) | 1994-07-13 |
DK0605497T3 (da) | 1996-08-05 |
HU227680B1 (en) | 2011-11-28 |
DK0605497T4 (da) | 1999-10-25 |
CZ59694A3 (en) | 1994-07-13 |
HU9400779D0 (en) | 1994-06-28 |
CZ289253B6 (cs) | 2001-12-12 |
GR3019750T3 (en) | 1996-07-31 |
EP0605497B1 (de) | 1996-03-20 |
HUT75165A (en) | 1997-04-28 |
CA2119253C (en) | 1998-11-03 |
DE4131562A1 (de) | 1993-03-25 |
EP0605497B2 (de) | 1999-04-14 |
JP2683575B2 (ja) | 1997-12-03 |
WO1993005768A1 (de) | 1993-04-01 |
AU672177B2 (en) | 1996-09-26 |
KR0141504B1 (ko) | 1998-06-01 |
DE59205783D1 (de) | 1996-04-25 |
GR3030291T3 (en) | 1999-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2085035T3 (es) | Soporte de particulas solidas de lipidos para medicamentos (nanoesferas solidas de lipidos (sln)). | |
ES2167308T3 (es) | Un sistema de distribucion de fosfolipidos. | |
IT1243745B (it) | Composizioni terapeutiche transdermali contenenti farmaco e/o agente promotore dell'assorbimento cutaneo supportato su particelle microporose e microsfere polimeriche e loro preparazione. | |
DE69835162D1 (de) | Geschmacksmaskierte pharmazeutische zusammensetzungen | |
DE69219600D1 (de) | Pharmazeutischer träger | |
JPS6452458A (en) | Multilayer administration system | |
FR2622442B1 (fr) | Supports de medicaments | |
AR002009A1 (es) | Composicion farmaceutica, procedimiento para la manufactura de un polvo de proliposoma como el utilizado en dicha composicion, procedimiento para lamanufactura de dicha composicion, uso de dicha composicion farmaceutica en la manufactura de un medicamento y dispositivo inhalador de polvo seco. | |
ES2134501T5 (es) | Composicion farmaceutica conteniendo un soporte fundible y procedimiento para su fabricacion. | |
ES2193161T3 (es) | Procedimiento para preparar microesferas lipidicas rellenas de gas y microesferas lipidicas relleneas de gas. | |
FR2683146B1 (fr) | Compositions pharmaceutiques a liberation reglee de la substance medicamenteuse. | |
ATE162072T1 (de) | Kleine partikeln enthaltende arzneistoffzusammensetzung | |
ATE464885T1 (de) | Verfahern zur herstellung von festen verabreichungssystemen für eingekapselte und nicht-eingekapselte pharmazeutische wirkstoffe | |
ES2149164T3 (es) | Nanoparticulas de farmacos de superficie modificada. | |
ES2029880T3 (es) | Dispositivo de liberacion de productos farmaceuticos. | |
ES2145992T3 (es) | Forma medicamentosa que sirve para administrar sustancias activas a las heridas. | |
ATE290854T1 (de) | Carbamazepinformulierung mit verzögerter freigabe | |
SE9704400D0 (sv) | Porous inorganic particles as carriers for drug substances | |
YU48228B (sh) | Transdermalni sistem sa stupnjevitim otpuštanjem aktivne materije | |
ATE87467T1 (de) | Pharmazeutische zubereitung. | |
DK165044C (da) | Indretning til intraruminal indgivelse af medikamenter | |
ES2054029T3 (es) | Formulacion de acetato de flecainida con liberacion controlada. | |
CO4230076A1 (es) | Proceso de infusion termica para preparar formas de medica- mentos de dosis solidas con liberacion controlada para ad- ministracion oral y los medicamentos preparados mediante es- te proceso. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 605497 Country of ref document: ES |